Literature DB >> 20735425

Induction of a novel cation current in cardiac ventricular myocytes by flufenamic acid and related drugs.

R Macianskiene1, A Gwanyanya, K R Sipido, J Vereecke, K Mubagwa.   

Abstract

BACKGROUND AND
PURPOSE: Interest in non-selective cation channels has increased recently following the discovery of transient receptor potential (TRP) proteins, which constitute many of these channels. EXPERIMENTAL APPROACH: We used the whole-cell patch-clamp technique on isolated ventricular myocytes to investigate the effect of flufenamic acid (FFA) and related drugs on membrane ion currents. KEY
RESULTS: With voltage-dependent and other ion channels inhibited, cells that were exposed to FFA, N-(p-amylcinnamoyl)anthranilic acid (ACA), ONO-RS-082 or niflumic acid (NFA) responded with an increase in currents. The induced current reversed at +38 mV, was unaffected by lowering extracellular Cl(-) concentration or by the removal of extracellular Ca(2+) and Mg(2+), and its inward but not outward component was suppressed in Na(+)-free extracellular conditions. The current was suppressed by Gd(3+) but was resistant to 2-aminoethoxydiphenyl borate (2-APB) and to amiloride. It could not be induced by the structurally related non-fenamate anti-inflammatory drug diclofenac, nor by the phospholipase-A(2) inhibitors bromoenol lactone and bromophenacyl bromide. Muscarinic or alpha-adrenoceptor activation or application of diacylglycerol failed to induce or modulate the current. CONCLUSIONS AND IMPLICATIONS: Flufenamic acid and related drugs activate a novel channel conductance, where Na(+) is likely to be the major charge carrier. The identity of the channel remains unclear, but it is unlikely to be due to Ca(2+)-activated (e.g. TRPM4/5), Mg(2+)-sensitive (e.g. TRPM7) or divalent cation-selective TRPs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20735425      PMCID: PMC2989592          DOI: 10.1111/j.1476-5381.2010.00901.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  57 in total

1.  TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells.

Authors:  Silke Jung; Rainer Strotmann; Günter Schultz; Tim D Plant
Journal:  Am J Physiol Cell Physiol       Date:  2002-02       Impact factor: 4.249

2.  Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism.

Authors:  Colleen E Clancy; Yoram Rudy
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

Review 3.  Hyperpolarization-activated cation currents: from molecules to physiological function.

Authors:  Richard B Robinson; Steven A Siegelbaum
Journal:  Annu Rev Physiol       Date:  2002-11-19       Impact factor: 19.318

Review 4.  TRP channels as cellular sensors.

Authors:  David E Clapham
Journal:  Nature       Date:  2003-12-04       Impact factor: 49.962

5.  A polycystin-2-like large conductance cation channel in rat left ventricular myocytes.

Authors:  Tilmann Volk; Alexander Peter Schwoerer; Susanne Thiessen; Jobst-Hendrik Schultz; Heimo Ehmke
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

6.  G protein-independent activation of an inward Na(+) current by muscarinic receptors in mouse pancreatic beta-cells.

Authors:  Jean-François Rolland; Jean-Claude Henquin; Patrick Gilon
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

7.  Ca2+-independent phospholipase A2 is a novel determinant of store-operated Ca2+ entry.

Authors:  Tarik Smani; Sergey I Zakharov; Endri Leno; Peter Csutora; Elena S Trepakova; Victoria M Bolotina
Journal:  J Biol Chem       Date:  2003-01-23       Impact factor: 5.157

8.  A novel, voltage-dependent nonselective cation current activated by insulin in guinea pig isolated ventricular myocytes.

Authors:  Yin Hua Zhang; Jules C Hancox
Journal:  Circ Res       Date:  2003-03-13       Impact factor: 17.367

9.  Monovalent cation (MC) current in cardiac and smooth muscle cells: regulation by intracellular Mg2+ and inhibition by polycations.

Authors:  Sergey I Zakharov; Tarik Smani; Endri Leno; Regina Macianskiene; Kanigula Mubagwa; Victoria M Bolotina
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

10.  Activation of the Ca(2+)-activated nonselective cation channel by diacylglycerol analogues in rat cardiomyocytes.

Authors:  Romain Guinamard; Aurélien Chatelier; Jacques Lenfant; Patrick Bois
Journal:  J Cardiovasc Electrophysiol       Date:  2004-03
View more
  6 in total

1.  Pharmacological comparison of novel synthetic fenamate analogues with econazole and 2-APB on the inhibition of TRPM2 channels.

Authors:  Gui-Lan Chen; Bo Zeng; Sarah Eastmond; Sandra E Elsenussi; Andrew N Boa; Shang-Zhong Xu
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Transient receptor potential melastatin 4 inhibitor 9-phenanthrol abolishes arrhythmias induced by hypoxia and re-oxygenation in mouse ventricle.

Authors:  Christophe Simard; Laurent Sallé; René Rouet; Romain Guinamard
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Flufenamic acid as an ion channel modulator.

Authors:  Romain Guinamard; Christophe Simard; Christopher Del Negro
Journal:  Pharmacol Ther       Date:  2013-01-25       Impact factor: 12.310

4.  Low concentrations of niflumic acid enhance basal spontaneous and carbachol-induced contractions of the detrusor.

Authors:  Wai Ping Lam; Hong Chai Tang; Xin Zhang; Ping Chung Leung; David Tai Wai Yew; Willmann Liang
Journal:  Int Urol Nephrol       Date:  2013-09-15       Impact factor: 2.370

5.  Upregulated LRRC55 promotes BK channel activation and aggravates cell injury in podocytes.

Authors:  Shuai Hu; Runhong Han; Long Chen; Weisong Qin; Xiaodong Xu; Jingsong Shi; Xiaodong Zhu; Mingchao Zhang; Caihong Zeng; Zheng Tang; Hao Bao; Zhihong Liu
Journal:  J Exp Med       Date:  2021-03-01       Impact factor: 14.307

Review 6.  Potential Drug Candidates to Treat TRPC6 Channel Deficiencies in the Pathophysiology of Alzheimer's Disease and Brain Ischemia.

Authors:  Veronika Prikhodko; Daria Chernyuk; Yurii Sysoev; Nikita Zernov; Sergey Okovityi; Elena Popugaeva
Journal:  Cells       Date:  2020-10-24       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.